Transcriptome analysis of FuZheng XiaoJi prescription inhibiting the proliferation of colorectal cancer

References

• Aran V, Victorino AP, Thuler LC, Ferreira CG. 2016. Colorectal cancer: epidemiology, disease mechanisms and interventions to reduce onset and mortality. Clin Colorectal Cancer. 15:195–203. doi:10.1016/j.clcc.2016.02.008
   PubMed Web of Science ®Google Scholar
• Chen D, Li Y, Zhang X, Wu H, Wang Q, Cai J, Cui Y, Liu H, Lan P, Wang J, et al. 2019b. Ubiquitin ligase TRIM65 promotes colorectal cancer metastasis by targeting ARHGAP35 for protein degradation. Oncogene. 38:6429–6444. doi:10.1038/s41388-019-0891-6
   Web of Science ®Google Scholar
• Chen X, Liu J, Zhang Q, Liu B, Cheng Y, Zhang Y, Sun Y, Ge H, Liu Y. 2020. Exosome-mediated transfer of miR-93-5p from cancer-associated fibroblasts confer radioresistance in colorectal cancer cells by downregulating FOXA1 and upregulating TGFB3. J Exp Clin Cancer Res. 39:65. doi:10.1186/s13046-019-1507-2
   PubMed Web of Science ®Google Scholar
• Chen C, Yao X, Xu Y, Zhang Q, Wang H, Zhao L, Wen G, Liu Y, Jing L, Sun X. 2019a. Dahuang Zhechong pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche. J Ethnopharmacol. 238:111878. doi:10.1016/j.jep.2019.111878
   Web of Science ®Google Scholar
• Chen X, Zeng K, Xu M, Hu X, Liu X, Xu T, He B, Pan Y, Sun H, Wang S. 2018. SP1-induced lncRNA-ZFAS1 contributes to colorectal cancer progression via the miR-150-5p/VEGFA axis. Cell Death Dis. 9:982. doi:10.1038/s41419-018-0962-6
   PubMed Web of Science ®Google Scholar
• Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. 2019. Colorectal cancer. Lancet. 394:1467–1480. doi:10.1016/s0140-6736(19)32319-0
   PubMed Web of Science ®Google Scholar
• Dweep H, Sticht C, Pandey P, Gretz N. 2011. miRWalk – database: prediction of possible miRNA binding sites by “walking” the genes of three genomes. J Biomed Inform. 44:839–847. doi:10.1016/j.jbi.2011.05.002
   PubMed Web of Science ®Google Scholar
• Faktor J, Pjechová M, Hernychová L, Vojtěšek B. 2019. Protein ubiquitination research in oncology. Klin Onkol Casopis Ceske Slovenske Onkologicke Spolecnosti. 32:56–64. doi:10.14735/amko20193S
   PubMedGoogle Scholar
• Grossi V, Peserico A, Tezil T, Simone C. 2014. P38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance. World J Gastroenterol. 20:9744–9758. doi:10.3748/wjg.v20.i29.9744
   PubMed Web of Science ®Google Scholar
• Han JD, Bertin N, Hao T, Goldberg DS, Berriz GF, Zhang LV, Dupuy D, Walhout AJ, Cusick ME, Roth FP, Vidal M. 2004. Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature. 430:88–93. doi:10.1038/nature02555
   PubMed Web of Science ®Google Scholar
• Han H, Cho JW, Lee S, Yun A, Kim H, Bae D, Yang S, Kim CY, Lee M, Kim E, et al. 2018. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 46:D380–d386. doi:10.1093/nar/gkx1013
   PubMed Web of Science ®Google Scholar
• Hong M, Zhang Z, Chen Q, Lu Y, Zhang J, Lin C, Zhang F, Zhang W, Li X, Zhang W, Li X. 2019. IRF1 inhibits the proliferation and metastasis of colorectal cancer by suppressing the RAS-RAC1 pathway. Cancer Manag Res. 11:369–378. doi:10.2147/cmar.s186236
   PubMed Web of Science ®Google Scholar
• Hu Y, Wang J. 2019. Interactions between clopidogrel and traditional Chinese medicine. J Thromb Thrombolysis. 48:491–499. doi:10.1007/s11239-019-01945-3
   PubMed Web of Science ®Google Scholar
• Huang RH, Quan YJ, Chen JH, Wang TF, Xu M, Ye M, Yuan H, Zhang CJ, Liu XJ, Min ZJ. 2017. Osteopontin promotes cell migration and invasion, and inhibits apoptosis and autophagy in colorectal cancer by activating the p38 MAPK signaling pathway. Cell Physiol Biochem. 41:1851–1864. doi:10.1159/000471933
   PubMed Web of Science ®Google Scholar
• Jiang Z, Zhou X, Li R, Michal JJ, Zhang S, Dodson MV, Zhang Z, Harland RM. 2015. Whole transcriptome analysis with sequencing: methods, challenges and potential solutions. Cell Mol Life Sci. 72:3425–3439. doi:10.1007/s00018-015-1934-y
   Web of Science ®Google Scholar
• Jing W. 2019. Clinical study of Fuzheng Xiaoji decoction combined with capecitabine and oxaliplatin in the treatment of advanced colon cancer. J Chang Med Coll. 33:467–430.
   Google Scholar
• Kai-jun C, Huiming W, Jiangping Q, Liping L, Caili L. 2015. The application value of Fuzheng Xiaoji decoction combined with chemotherapy medicine in treating advanced colon cancer. CJGMCM. 30:2638–2640.
   Google Scholar
• Kim D, Langmead B, Salzberg SL. 2015. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 12:357–360. doi:10.1038/nmeth.3317
   PubMed Web of Science ®Google Scholar
• Kim SH, Park YY, Cho SN, Margalit O, Wang D, DuBois RN. 2016. Krüppel-like factor 12 promotes colorectal cancer growth through early growth response protein 1. PLoS One. 11:e0159899. doi:10.1371/journal.pone.0159899
   Web of Science ®Google Scholar
• Klopfenstein DV, Zhang L, Pedersen BS, Ramírez F, Warwick Vesztrocy A, Naldi A, Mungall CJ, Yunes JM. 2018. GOATOOLS: a python library for gene ontology analyses. Sci Rep. 8:10872. doi:10.1038/s41598-018-28948-z
   PubMed Web of Science ®Google Scholar
• Koelzer VH, Sokol L, Zahnd S, Christe L, Dawson H, Berger MD, Inderbitzin D, Zlobec I, Lugli A. 2017. Digital analysis and epigenetic regulation of the signature of rejection in colorectal cancer. Oncoimmunology. 6:e1288330. doi:10.1080/2162402x.2017.1288330
   PubMed Web of Science ®Google Scholar
• Kumar SS, Tomita Y, Wrin J, Bruhn M, Swalling A, Mohammed M, Price TJ, Hardingham JE. 2017. High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab. Clin Transl Oncol. 19:718–726. doi:10.1007/s12094-016-1596-8
   PubMed Web of Science ®Google Scholar
• Lee K, Cho SG, Choi YK, Choi YJ, Lee GR, Jeon CY, Ko SG. 2018. Herbal prescription, Danggui-Sayuk-Ga-Osuyu-Senggang-Tang, inhibits TNF-α-induced epithelial-mesenchymal transition in HCT116 colorectal cancer cells. Int J Mol Med. 41:373–380. doi:10.3892/ijmm.2017.3241
   Web of Science ®Google Scholar
• Liu L, Zhang Y, Wong CC, Zhang J, Dong Y, Li X, Kang W, Chan FKL, Sung JJY, Yu J. 2018. RNF6 promotes colorectal cancer by activating the Wnt/β-catenin pathway via ubiquitination of TLE3. Cancer Res. 78:1958–1971. doi:10.1158/0008-5472.can-17-2683
   Web of Science ®Google Scholar
• Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15:550. doi:10.1186/s13059-014-0550-8
   PubMed Web of Science ®Google Scholar
• Mansour MA. 2018. Ubiquitination: friend and foe in cancer. Int J Biochem Cell Biol. 101:80–93. doi:10.1016/j.biocel.2018.06.001
   PubMed Web of Science ®Google Scholar
• Mody K, Baldeo C, Bekaii-Saab T. 2018. Antiangiogenic therapy in colorectal cancer. Cancer J. 24:165–170. doi:10.1097/ppo.0000000000000328
   PubMed Web of Science ®Google Scholar
• Ohsugi T, Yamaguchi K. 2019. Anti-apoptotic effect by the suppression of IRF1 as a downstream of Wnt/β-catenin signaling in colorectal cancer cells. Oncogene. 38:6051–6064. doi:10.1038/s41388-019-0856-9
   Web of Science ®Google Scholar
• Osumi H, Shinozaki E, Yamaguchi K, Zembutsu H. 2019. Clinical utility of circulating tumor DNA for colorectal cancer. Cancer Sci. 110:1148–1155. doi:10.1111/cas.13972
   PubMed Web of Science ®Google Scholar
• Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL. 2015. Stringtie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol. 33:290–295. doi:10.1038/nbt.3122
   PubMed Web of Science ®Google Scholar
• Piel FB, Steinberg MH, Rees DC. 2017. Sickle cell disease. N Engl J Med. 376:1561–1573. doi:10.1056/NEJMra1510865
   PubMed Web of Science ®Google Scholar
• Schneider D, Chua RL, Molitor N, Hamdan FH, Rettenmeier EM, Prokakis E, Mishra VK, Kari V, Wegwitz F, Johnsen SA, Kosinsky RL. 2019. The E3 ubiquitin ligase RNF40 suppresses apoptosis in colorectal cancer cells. Clin Epigenet. 11:98. doi:10.1186/s13148-019-0698-x
   PubMed Web of Science ®Google Scholar
• Snyder R, Thekkumkara T. 2013. Interplay between EGR1 and SP1 is critical for 13-cis retinoic acid-mediated transcriptional repression of angiotensin type 1A receptor. J Mol Endocrinol. 50:361–374. doi:10.1530/jme-12-0154
   Web of Science ®Google Scholar
• Sturm M, Schroeder C, Bauer P. 2016. Seqpurge: highly-sensitive adapter trimming for paired-end NGS data. BMC Bioinform. 17:208. doi:10.1186/s12859-016-1069-7
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu WZ, Liu T, Feng X, Yang N, Zhou HF. 2015. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res 35:600–604. doi:10.3109/10799893.2015.1030412
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, et al. 2019. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47:D607–d613. doi:10.1093/nar/gky1131
   PubMed Web of Science ®Google Scholar
• Tang B, Liang W, Liao Y, Li Z, Wang Y, Yan C. 2019. PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway. Oncol Rep 41:43–56. doi:10.3892/or.2018.6825
   PubMed Web of Science ®Google Scholar
• Tang Q, Zou Z, Zou C, Zhang Q, Huang R, Guan X, Li Q, Han Z, Wang D, Wei H, et al. 2015. MicroRNA-93 suppress colorectal cancer development via Wnt/β-catenin pathway downregulating. Oncol ReportsTumour Biol. 36:1701–1710. doi:10.1007/s13277-014-2771-6
   Google Scholar
• Thanikachalam K, Khan G. 2019. Colorectal cancer and nutrition. Nutrients. 11:164. doi:10.3390/nu11010164
   PubMed Web of Science ®Google Scholar
• Vizcaíno C, Mansilla S, Portugal J. 2015. Sp1 transcription factor: a long-standing target in cancer chemotherapy. Pharmacol Ther. 152:111–124. doi:10.1016/j.pharmthera.2015.05.008
   PubMed Web of Science ®Google Scholar
• Wang J, Wong YK, Liao F. 2018. What has traditional Chinese medicine delivered for modern medicine? Expert Rev Mol Med. 20:e4. doi:10.1017/erm.2018.3
   PubMed Web of Science ®Google Scholar
• Woolston A, Khan K, Spain G, Barber LJ, Griffiths B, Gonzalez-Exposito R, Hornsteiner L, Punta M, Patil Y, Newey A, et al. 2019. Genomic and transcriptomic determinants of therapy resistance and immune landscape evolution during anti-EGFR treatment in colorectal cancer. Cancer Cell. 36:35–50. doi:10.1016/j.ccell.2019.05.013
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhang S, Yan J. 2020. IRF1 association with tumor immune microenvironment and use as a diagnostic biomarker for colorectal cancer recurrence. Oncol Lett. 19:1759–1770. doi:10.3892/ol.2020.11289
   PubMed Web of Science ®Google Scholar
• Xu X, Huang A, Cui X, Han K, Hou X, Wang Q, Cui L, Yang Y. 2019. Ubiquitin specific peptidase 5 regulates colorectal cancer cell growth by stabilizing Tu translation elongation factor. Theranostics. 9:4208–4220. doi:10.7150/thno.33803
   PubMed Web of Science ®Google Scholar
• Xu Y, Mao JJ, Sun L, Yang L, Li J, Hao Y, Li H, Hou W, Chu Y, Bai Y, et al. 2017. Association between use of traditional Chinese medicine herbal therapy and survival outcomes in patients with stage II and III colorectal cancer: a multicenter prospective cohort study. J Natl Cancer Inst Monogr. 2017. doi:10.1093/jncimonographs/lgx015
   Google Scholar
• Yu Y, Peng K, Li H, Zhuang R, Wang Y, Li W, Yu S, Liang L, Xu X, Liu T. 2018. SP1 upregulated FoxO3à promotes tumor progression in colorectal cancer. Oncol Rep. 39:2235–2242. doi:10.3892/or.2018.6323
   Web of Science ®Google Scholar
• Yu S, Wang D, Shao Y, Zhang T, Xie H, Jiang X, Deng Q, Jiao Y, Yang J, Cai C, Sun L. 2019. SP1-induced lncRNA TINCR overexpression contributes to colorectal cancer progression by sponging miR-7-5p. Aging. 11:1389–1403. doi:10.18632/aging.101839
   PubMedGoogle Scholar
• Zhao DY, Jacobs KM, Hallahan DE, Thotala D. 2015. Silencing Egr1 attenuates radiation-induced apoptosis in normal tissues while killing cancer cells and delaying tumor growth. Mol Cancer Ther. 14:2343–2352. doi:10.1158/1535-7163.mct-14-1051
   PubMed Web of Science ®Google Scholar